1. Home
  2. STTK vs PWOD Comparison

STTK vs PWOD Comparison

Compare STTK & PWOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STTK
  • PWOD
  • Stock Information
  • Founded
  • STTK 2016
  • PWOD 1934
  • Country
  • STTK United States
  • PWOD United States
  • Employees
  • STTK N/A
  • PWOD N/A
  • Industry
  • STTK Biotechnology: Pharmaceutical Preparations
  • PWOD Major Banks
  • Sector
  • STTK Health Care
  • PWOD Finance
  • Exchange
  • STTK Nasdaq
  • PWOD Nasdaq
  • Market Cap
  • STTK 37.6M
  • PWOD 231.2M
  • IPO Year
  • STTK 2020
  • PWOD N/A
  • Fundamental
  • Price
  • STTK $0.79
  • PWOD $31.41
  • Analyst Decision
  • STTK Hold
  • PWOD
  • Analyst Count
  • STTK 4
  • PWOD 0
  • Target Price
  • STTK $3.00
  • PWOD N/A
  • AVG Volume (30 Days)
  • STTK 470.6K
  • PWOD 75.5K
  • Earning Date
  • STTK 07-31-2025
  • PWOD 07-24-2025
  • Dividend Yield
  • STTK N/A
  • PWOD 3.97%
  • EPS Growth
  • STTK N/A
  • PWOD 28.19
  • EPS
  • STTK N/A
  • PWOD 2.80
  • Revenue
  • STTK $4,606,000.00
  • PWOD $74,314,000.00
  • Revenue This Year
  • STTK N/A
  • PWOD N/A
  • Revenue Next Year
  • STTK N/A
  • PWOD N/A
  • P/E Ratio
  • STTK N/A
  • PWOD $11.53
  • Revenue Growth
  • STTK 69.65
  • PWOD 16.68
  • 52 Week Low
  • STTK $0.69
  • PWOD $20.18
  • 52 Week High
  • STTK $4.99
  • PWOD $34.56
  • Technical
  • Relative Strength Index (RSI)
  • STTK 39.92
  • PWOD 56.84
  • Support Level
  • STTK $0.75
  • PWOD $31.73
  • Resistance Level
  • STTK $0.85
  • PWOD $32.46
  • Average True Range (ATR)
  • STTK 0.08
  • PWOD 0.64
  • MACD
  • STTK -0.01
  • PWOD 0.06
  • Stochastic Oscillator
  • STTK 10.56
  • PWOD 62.07

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

About PWOD Penns Woods Bancorp Inc.

Penns Woods Bancorp Inc is the bank holding company for Jersey Shore State Bank and Luzerne Bank. The banks serve customers in North Central and North Eastern Pennsylvania through their retail banking, commercial banking, mortgage services and financial services divisions. The Banks are engaged in commercial and retail banking which includes the acceptance of time, savings, and demand deposits, the funding of commercial, consumer, and mortgage loans, and safe deposit services. Utilizing a branch office network, ATMs, Internet, and telephone banking delivery channels, the Banks deliver their products and services to the communities residing in.

Share on Social Networks: